On October 5, 2007, Lions Capital Corp. acquired the fund management agreement for Pender NDI Life Sciences Fund ("Pender NDI") from Pender Fund Capital Management Ltd., a wholly owned subsidiary of Pender Financial Group Corp. Lions Capital is the fund manager of BC Advantage Funds ("Advantage") and Lions Liquidity Investment Fund I Limited Partnership and manages more than $57 million of venture capital. Lions Capital also provides financing, merger and acquisition, and financial advisory services to life science and technology companies.
Lions Capital was advised in this acquisition by a team from Fasken Martineau that included Gary Ott, Iain Mant, Prentice Durbin, Andrey Schmidt and Andrew Jackson.